Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lawrence

Showing results (1021-1030 of 1,491) with videos related to

Pageof 150
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 1, 2012
Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapyMatthew H Stenmark, Xu-Wei Cai, Kerby Shedden, et al.
Thyroid : Official Journal of the American Thyroid Association|December 9, 2023
Social Vulnerability Association with Thyroid Cancer Disparities in the United StatesDavid Jun Fei-Zhang, Rhea Verma, Ryuji Arimoto, et al.
Nature Reviews. Disease Primers|November 9, 2023
Cryptococcal meningitisLillian Tugume, Kenneth Ssebambulidde, John Kasibante, et al.
The Journal of Biological Chemistry|March 14, 2020
The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activityWei Huang, Paramita Ray, Wenbin Ji, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of HepatotoxicityMatthew M Cousins, Theresa P Devasia, Christopher M Maurino, et al.
The Journal of Clinical Investigation|December 15, 2007
TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor developmentAnne Grosse-Wilde, Oksana Voloshanenko, S Lawrence Bailey, et al.
American Journal of Preventive Medicine|October 26, 2005
A quantitative analysis of fish consumption and coronary heart disease mortalityAriane König, Colleen Bouzan, Joshua T Cohen, et al.
Neoplasia (New York, N.Y.)|November 21, 2015
Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination RepairTasneem Kausar, Jason S Schreiber, David Karnak, et al.
Neoplasia (New York, N.Y.)|November 9, 2013
Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibitionSumin Han, J Chad Brenner, Aaron Sabolch, et al.
Neoplasia (New York, N.Y.)|April 9, 2014
Efficacy of an EGFR-specific peptide against EGFR-dependent cancer cell lines and tumor xenograftsAarif Ahsan, Susmita G Ramanand, Ingrid L Bergin, et al.
Pageof 150

Showing results (1021-1030 of 1,491) with videos related to

Sort By:
Pageof 150
International Journal of Radiation Oncology, Biology, Physics|September 1, 2012
Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapyMatthew H Stenmark, Xu-Wei Cai, Kerby Shedden, et al.
Thyroid : Official Journal of the American Thyroid Association|December 9, 2023
Social Vulnerability Association with Thyroid Cancer Disparities in the United StatesDavid Jun Fei-Zhang, Rhea Verma, Ryuji Arimoto, et al.
Nature Reviews. Disease Primers|November 9, 2023
Cryptococcal meningitisLillian Tugume, Kenneth Ssebambulidde, John Kasibante, et al.
The Journal of Biological Chemistry|March 14, 2020
The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activityWei Huang, Paramita Ray, Wenbin Ji, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of HepatotoxicityMatthew M Cousins, Theresa P Devasia, Christopher M Maurino, et al.
The Journal of Clinical Investigation|December 15, 2007
TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor developmentAnne Grosse-Wilde, Oksana Voloshanenko, S Lawrence Bailey, et al.
American Journal of Preventive Medicine|October 26, 2005
A quantitative analysis of fish consumption and coronary heart disease mortalityAriane König, Colleen Bouzan, Joshua T Cohen, et al.
Neoplasia (New York, N.Y.)|November 21, 2015
Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination RepairTasneem Kausar, Jason S Schreiber, David Karnak, et al.
Neoplasia (New York, N.Y.)|November 9, 2013
Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibitionSumin Han, J Chad Brenner, Aaron Sabolch, et al.
Neoplasia (New York, N.Y.)|April 9, 2014
Efficacy of an EGFR-specific peptide against EGFR-dependent cancer cell lines and tumor xenograftsAarif Ahsan, Susmita G Ramanand, Ingrid L Bergin, et al.
Pageof 150